APA (7th ed.) Citation

Morris, W. J., Tyldesley, S., Rodda, S., Halperin, R., Pai, H., McKenzie, M., . . . Murray, N. (2017). Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer. International journal of radiation oncology, biology, physics, 98(2), 275-285. https://doi.org/10.1016/j.ijrobp.2016.11.026

Chicago Style (17th ed.) Citation

Morris, W. James, et al. "Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing A Low-Dose-Rate Brachytherapy Boost to A Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer." International Journal of Radiation Oncology, Biology, Physics 98, no. 2 (2017): 275-285. https://doi.org/10.1016/j.ijrobp.2016.11.026.

MLA (9th ed.) Citation

Morris, W. James, et al. "Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing A Low-Dose-Rate Brachytherapy Boost to A Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer." International Journal of Radiation Oncology, Biology, Physics, vol. 98, no. 2, 2017, pp. 275-285, https://doi.org/10.1016/j.ijrobp.2016.11.026.